NCT06008093
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06008093
Title A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients (TRITON)
Acronym TRITON
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Beverly Hills California 90211 United States Details
Research Site La Jolla California 92093 United States Details
Research Site Los Alamitos California 90720 United States Details
Research Site Los Angeles California 90034 United States Details
Research Site Santa Monica California 90404 United States Details
Research Site Washington D.C. District of Columbia 20007 United States Details
Research Site Fort Lauderdale Florida 33308 United States Details
Research Site Jupiter Florida 33458 United States Details
Research Site Ocala Florida 34474 United States Details
Research Site Orlando Florida 32804 United States Details
Research Site St. Petersburg Florida 33705 United States Details
Research Site Atlanta Georgia 30318 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Honolulu Hawaii 96813 United States Details
Research Site Carterville Illinois 62918 United States Details
Research Site Urbana Illinois 61801 United States Details
Research Site Bethesda Maryland 20817 United States Details
Research Site Jamaica Plain Massachusetts 02130 United States Details
Research Site Saint Paul Minnesota 55101 United States Details
Research Site Kansas City Missouri 64132 United States Details
Research Site St Louis Missouri 63128 United States Details
Research Site Billings Montana 59102 United States Details
Research Site Grand Island Nebraska 68803 United States Details
Research Site Lincoln Nebraska 68506 United States Details
Research Site Albany New York 12206 United States Details
Research Site East Syracuse New York 13057 United States Details
Research Site New York New York 10032 United States Details
Research Site Shirley New York 11967 United States Details
Research Site Stony Brook New York 11790 United States Details
Research Site Syracuse New York 13210 United States Details
Research Site The Bronx New York 10461 United States Details
Research Site Cleveland Ohio 44111 United States Details
Research Site Cleveland Ohio 44124 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Dayton Ohio 45459 United States Details
Research Site Norman Oklahoma 73072 United States Details
Research Site Pittsburgh Pennsylvania 15212 United States Details
Research Site Sioux Falls South Dakota 57105 United States Details
Research Site Memphis Tennessee 38120 United States Details
Research Site Dallas Texas 75246 United States Details
Research Site Denton Texas 76210 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Houston Texas 77090 United States Details
Research Site Kingwood Texas 77339 United States Details
Research Site Fairfax Virginia 22031 United States Details
Research Site Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field